Kimberly-Clark, the maker of Huggies and Kleenex, announced a $48.7 billion deal to acquire Kenvue, the parent company of Tylenol, creating one of the largest consumer goods companies in the world.
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company. https://t.co/UViO14Fjxj
— The Associated Press (@AP) November 3, 2025
The merger will unite ten billion-dollar brands, including Johnson’s Baby, Listerine, and Clean & Clear, generating an estimated $32 billion in annual revenue.
The announcement follows weeks of controversy after President Donald Trump claimed, without evidence, that Tylenol causes autism in pregnant women — a statement that caused Kenvue’s stock to tumble. Kenvue has strongly denied the accusation.
Kimberly-Clark has agreed to buy Kenvue in a $48.7 billion deal including debt, combining the maker of Huggies diapers with the owner of Tylenol and other consumer healthcare products https://t.co/vlOUhksqfL
— WSJ Business News (@WSJbusiness) November 3, 2025
Under the deal, Kimberly-Clark will pay $21.01 per Kenvue share, a 46% premium over Friday’s closing price. The transaction is expected to close in the second half of next year, with Kimberly-Clark shareholders owning 54% of the new company.
However, Kenvue faces declining sales and a new lawsuit filed by Texas Attorney General Ken Paxton over alleged deceptive marketing practices.
Also read:

